Sree Rayalaseema Hi-Strength Hypo Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 17, 2025, 10:22 am

Market Cap	846 Cr.
Current Price	493
High / Low	944/439
Stock P/E	8.93
Book Value	510
Dividend Yield	0.61 %
ROCE	15.7 %
ROE	11.4 %
Face Value	10.0
PEG Ratio	1.06

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Sree Rayalaseema Hi-Strength Hypo Ltd

Competitors of Sree Rayalaseema Hi-Strength Hypo Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Fischer Medical Ventures Ltd	4,317 Cr.	807	907/454	1,927	15.2	0.00 %	5.25 %	4.55 %	10.0
Emmessar Biotech & Nutrition Ltd	16.2 Cr.	32.5	64.0/27.2	21.4	15.6	0.00 %	11.4 %	10.6 %	10.0
Cochin Minerals & Rutile Ltd	197 Cr.	252	415/239	17.7	198	3.18 %	26.6 %	5.82 %	10.0
Archean Chemical Industries Ltd	7,058 Cr.	572	832/408	32.3	143	0.52 %	25.8 %	19.4 %	2.00
Alufluoride Ltd	320 Cr.	409	581/341	14.4	122	0.73 %	25.1 %	22.2 %	10.0
Industry Average	5,345.13 Cr	513.85		218.12	146.20	0.53%	15.23%	10.70%	7.82

All Competitor Stocks of Sree Rayalaseema Hi-Strength Hypo Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	295	414	570	344	301	435	261	226	215	165	169	170	138
Expenses	245	372	517	310	274	371	226	199	192	138	142	140	117
Operating Profit	51	43	53	34	26	64	35	26	22	27	27	30	21
OPM %	17%	10%	9%	10%	9%	15%	13%	12%	10%	16%	16%	18%	15%
Other Income	0	7	0	3	11	20	1	2	4	5	3	9	13
Interest	5	0	0	1	0	1	1	1	1	2	0	0	0
Depreciation	5	5	4	5	5	5	3	3	3	3	1	2	1
Profit before tax	41	44	49	31	32	79	33	25	23	27	28	36	32
Tax %	35%	15%	26%	24%	26%	9%	26%	27%	29%	23%	26%	29%	27%
Net Profit	27	37	36	24	24	71	24	18	17	21	20	26	24
EPS in Rs	15.49	21.75	20.94	13.79	13.72	41.45	14.17	10.78	9.69	12.22	11.94	15.12	13.71

Last Updated: February 28, 2025, 4:59 pm

Below is a detailed analysis of the quarterly data for Sree Rayalaseema Hi-Strength Hypo Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹138.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Sep 2024) to ₹138.00 Cr., marking a decrease of 32.00 Cr..
For Expenses, as of Dec 2024, the value is ₹117.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 140.00 Cr. (Sep 2024) to ₹117.00 Cr., marking a decrease of 23.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Sep 2024) to ₹21.00 Cr., marking a decrease of 9.00 Cr..
For OPM %, as of Dec 2024, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Sep 2024) to 15.00%, marking a decrease of 3.00%.
For Other Income, as of Dec 2024, the value is ₹13.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Sep 2024) to ₹13.00 Cr., marking an increase of ₹4.00 Cr..
For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Sep 2024) to ₹1.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Sep 2024) to ₹32.00 Cr., marking a decrease of 4.00 Cr..
For Tax %, as of Dec 2024, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Sep 2024) to 27.00%, marking a decrease of 2.00%.
For Net Profit, as of Dec 2024, the value is ₹24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Sep 2024) to ₹24.00 Cr., marking a decrease of 2.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 13.71. The value appears to be declining and may need further review. It has decreased from ₹15.12 (Sep 2024) to 13.71, marking a decrease of ₹1.41.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 6:46 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	299	295	392	362	366	546	702	689	911	1,267	1,650	866	643
Expenses	258	262	351	318	317	500	604	587	781	1,119	1,470	755	538
Operating Profit	41	33	41	44	50	46	98	102	130	149	180	111	105
OPM %	14%	11%	10%	12%	14%	8%	14%	15%	14%	12%	11%	13%	16%
Other Income	-4	9	9	2	-2	19	5	4	7	11	34	13	29
Interest	10	16	14	11	8	9	16	10	5	3	5	4	3
Depreciation	13	15	10	10	25	19	45	50	51	19	19	11	7
Profit before tax	13	12	26	26	15	37	42	45	81	137	190	109	124
Tax %	27%	36%	25%	27%	-27%	1%	52%	17%	25%	25%	19%	26%
Net Profit	9	7	19	19	18	37	20	38	61	103	154	80	91
EPS in Rs	6.53	5.06	13.16	12.72	11.86	22.45	11.90	22.09	35.30	59.88	89.90	46.85	52.99
Dividend Payout %	0%	0%	11%	12%	13%	9%	17%	11%	8%	6%	4%	6%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-22.22%	171.43%	0.00%	-5.26%	105.56%	-45.95%	90.00%	60.53%	68.85%	49.51%	-48.05%
Change in YoY Net Profit Growth (%)	0.00%	193.65%	-171.43%	-5.26%	110.82%	-151.50%	135.95%	-29.47%	8.33%	-19.34%	-97.57%

Sree Rayalaseema Hi-Strength Hypo Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	11%
5 Years:	4%
3 Years:	-2%
TTM:	-43%

Compounded Profit Growth
10 Years:	28%
5 Years:	36%
3 Years:	13%
TTM:	-30%

Stock Price CAGR
10 Years:	26%
5 Years:	43%
3 Years:	-1%
1 Year:	-3%

Return on Equity
10 Years:	14%
5 Years:	17%
3 Years:	17%
Last Year:	11%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:43 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	14	15	15	15	15	16	17	17	17	17	17	17	17
Reserves	126	135	157	173	222	302	308	294	371	553	734	785	859
Borrowings	117	88	87	85	55	78	52	57	72	28	16	5	14
Other Liabilities	101	130	99	84	60	64	93	76	59	189	174	100	118
Total Liabilities	358	367	358	357	352	460	470	445	519	787	941	907	1,008
Fixed Assets	155	200	194	195	182	194	194	161	134	130	105	103	109
CWIP	52	0	5	2	8	0	0	3	0	0	0	0	0
Investments	31	32	23	23	43	105	65	18	50	164	268	253	345
Other Assets	120	135	136	137	118	161	210	262	334	494	568	551	554
Total Assets	358	367	358	357	352	460	470	445	519	787	941	907	1,008

Below is a detailed analysis of the balance sheet data for Sree Rayalaseema Hi-Strength Hypo Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹17.00 Cr..
For Reserves, as of Sep 2024, the value is ₹859.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹785.00 Cr. (Mar 2024) to ₹859.00 Cr., marking an increase of 74.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹14.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹5.00 Cr. (Mar 2024) to ₹14.00 Cr., marking an increase of 9.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹118.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹100.00 Cr. (Mar 2024) to ₹118.00 Cr., marking an increase of 18.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹1,008.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹907.00 Cr. (Mar 2024) to ₹1,008.00 Cr., marking an increase of 101.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹109.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹103.00 Cr. (Mar 2024) to ₹109.00 Cr., marking an increase of 6.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Investments, as of Sep 2024, the value is ₹345.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹253.00 Cr. (Mar 2024) to ₹345.00 Cr., marking an increase of 92.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹554.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹551.00 Cr. (Mar 2024) to ₹554.00 Cr., marking an increase of 3.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹1,008.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹907.00 Cr. (Mar 2024) to ₹1,008.00 Cr., marking an increase of 101.00 Cr..

Notably, the Reserves (₹859.00 Cr.) exceed the Borrowings (14.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	47	20	36	15	47	5	60	99	71	60	131	132
Cash from Investing Activity +	-68	-9	-5	-3	-19	-27	-24	-38	-115	-1	-99	-8
Cash from Financing Activity +	21	-9	-32	-12	-19	16	-37	-22	10	-52	-20	-22
Net Cash Flow	-0	2	-1	-0	8	-6	-1	40	-35	7	12	103

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-76.00	-55.00	-46.00	-41.00	-5.00	-32.00	46.00	45.00	58.00	121.00	164.00	106.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	35	33	33	54	30	38	46	43	39	38	33	45
Inventory Days	50	67	42	37	55	34	34	36	27	62	39	24
Days Payable	86	97	79	39	66	21	38	24	8	33	22	10
Cash Conversion Cycle	-0	3	-4	51	19	51	41	55	57	67	50	59
Working Capital Days	23	15	12	48	42	48	52	46	48	53	47	67
ROCE %	13%	11%	13%	14%	9%	9%	14%	15%	21%	26%	26%	16%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	62.09%	62.09%	62.09%	62.09%	62.09%	62.09%	62.09%	62.09%	61.84%	61.84%	61.84%	61.84%
FIIs	0.00%	0.20%	0.14%	0.71%	0.74%	0.59%	0.60%	0.64%	0.65%	0.57%	0.55%	0.14%
DIIs	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%
Public	37.86%	37.67%	37.72%	37.16%	37.12%	37.28%	37.27%	37.23%	37.48%	37.56%	37.57%	37.99%
No. of Shareholders	59,522	59,058	59,283	62,802	64,522	65,045	47,181	48,576	48,539	47,510	46,565	45,411

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	46.01	89.97	59.88	35.29	22.08
Diluted EPS (Rs.)	46.01	89.97	59.88	35.29	22.08
Cash EPS (Rs.)	52.18	101.14	71.08	64.77	51.37
Book Value[Excl.RevalReserv]/Share (Rs.)	466.47	437.58	332.26	226.03	181.51
Book Value[Incl.RevalReserv]/Share (Rs.)	466.47	437.58	332.26	226.03	181.51
Revenue From Operations / Share (Rs.)	504.53	961.34	738.30	530.63	401.46
PBDIT / Share (Rs.)	77.32	124.97	92.87	79.77	61.69
PBIT / Share (Rs.)	71.14	113.70	81.67	50.29	32.40
PBT / Share (Rs.)	62.50	110.93	79.80	47.10	26.48
Net Profit / Share (Rs.)	46.01	89.87	59.88	35.29	22.08
NP After MI And SOA / Share (Rs.)	46.01	89.87	59.88	35.29	22.08
PBDIT Margin (%)	15.32	12.99	12.57	15.03	15.36
PBIT Margin (%)	14.10	11.82	11.06	9.47	8.06
PBT Margin (%)	12.38	11.53	10.80	8.87	6.59
Net Profit Margin (%)	9.11	9.34	8.11	6.65	5.50
NP After MI And SOA Margin (%)	9.11	9.34	8.11	6.65	5.50
Return on Networth / Equity (%)	9.86	20.54	18.02	15.61	12.16
Return on Capital Employeed (%)	14.20	25.52	24.05	21.55	16.86
Return On Assets (%)	8.64	17.18	13.04	11.67	8.52
Long Term Debt / Equity (X)	0.01	0.00	0.00	0.00	0.00
Total Debt / Equity (X)	0.01	0.01	0.03	0.15	0.12
Asset Turnover Ratio (%)	0.95	1.96	1.94	1.89	0.00
Current Ratio (X)	9.75	4.17	2.35	2.65	2.15
Quick Ratio (X)	9.17	3.22	1.65	2.32	1.83
Inventory Turnover Ratio (X)	5.03	4.24	5.39	9.03	0.00
Dividend Payout Ratio (NP) (%)	8.69	3.89	5.01	7.08	10.91
Dividend Payout Ratio (CP) (%)	7.66	3.46	4.22	3.86	4.69
Earning Retention Ratio (%)	91.31	96.11	94.99	92.92	89.09
Cash Earning Retention Ratio (%)	92.34	96.54	95.78	96.14	95.31
Interest Coverage Ratio (X)	33.31	45.16	49.69	25.01	10.42
Interest Coverage Ratio (Post Tax) (X)	23.54	33.48	33.04	12.06	4.73
Enterprise Value (Cr.)	518.25	489.04	718.64	328.19	77.14
EV / Net Operating Revenue (X)	0.59	0.29	0.56	0.36	0.11
EV / EBITDA (X)	3.90	2.28	4.51	2.40	0.72
MarketCap / Net Operating Revenue (X)	0.97	0.42	0.64	0.44	0.17
Retention Ratios (%)	91.30	96.10	94.98	92.91	89.08
Price / BV (X)	1.05	0.94	1.43	1.05	0.39
Price / Net Operating Revenue (X)	0.97	0.42	0.64	0.44	0.17
EarningsYield	0.09	0.21	0.12	0.14	0.30

After reviewing the key financial ratios for Sree Rayalaseema Hi-Strength Hypo Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 46.01. This value is within the healthy range. It has decreased from 89.97 (Mar 23) to 46.01, marking a decrease of 43.96.
For Diluted EPS (Rs.), as of Mar 24, the value is 46.01. This value is within the healthy range. It has decreased from 89.97 (Mar 23) to 46.01, marking a decrease of 43.96.
For Cash EPS (Rs.), as of Mar 24, the value is 52.18. This value is within the healthy range. It has decreased from 101.14 (Mar 23) to 52.18, marking a decrease of 48.96.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 466.47. It has increased from 437.58 (Mar 23) to 466.47, marking an increase of 28.89.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 466.47. It has increased from 437.58 (Mar 23) to 466.47, marking an increase of 28.89.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 504.53. It has decreased from 961.34 (Mar 23) to 504.53, marking a decrease of 456.81.
For PBDIT / Share (Rs.), as of Mar 24, the value is 77.32. This value is within the healthy range. It has decreased from 124.97 (Mar 23) to 77.32, marking a decrease of 47.65.
For PBIT / Share (Rs.), as of Mar 24, the value is 71.14. This value is within the healthy range. It has decreased from 113.70 (Mar 23) to 71.14, marking a decrease of 42.56.
For PBT / Share (Rs.), as of Mar 24, the value is 62.50. This value is within the healthy range. It has decreased from 110.93 (Mar 23) to 62.50, marking a decrease of 48.43.
For Net Profit / Share (Rs.), as of Mar 24, the value is 46.01. This value is within the healthy range. It has decreased from 89.87 (Mar 23) to 46.01, marking a decrease of 43.86.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 46.01. This value is within the healthy range. It has decreased from 89.87 (Mar 23) to 46.01, marking a decrease of 43.86.
For PBDIT Margin (%), as of Mar 24, the value is 15.32. This value is within the healthy range. It has increased from 12.99 (Mar 23) to 15.32, marking an increase of 2.33.
For PBIT Margin (%), as of Mar 24, the value is 14.10. This value is within the healthy range. It has increased from 11.82 (Mar 23) to 14.10, marking an increase of 2.28.
For PBT Margin (%), as of Mar 24, the value is 12.38. This value is within the healthy range. It has increased from 11.53 (Mar 23) to 12.38, marking an increase of 0.85.
For Net Profit Margin (%), as of Mar 24, the value is 9.11. This value is within the healthy range. It has decreased from 9.34 (Mar 23) to 9.11, marking a decrease of 0.23.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.11. This value is within the healthy range. It has decreased from 9.34 (Mar 23) to 9.11, marking a decrease of 0.23.
For Return on Networth / Equity (%), as of Mar 24, the value is 9.86. This value is below the healthy minimum of 15. It has decreased from 20.54 (Mar 23) to 9.86, marking a decrease of 10.68.
For Return on Capital Employeed (%), as of Mar 24, the value is 14.20. This value is within the healthy range. It has decreased from 25.52 (Mar 23) to 14.20, marking a decrease of 11.32.
For Return On Assets (%), as of Mar 24, the value is 8.64. This value is within the healthy range. It has decreased from 17.18 (Mar 23) to 8.64, marking a decrease of 8.54.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 23) to 0.01, marking an increase of 0.01.
For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.95. It has decreased from 1.96 (Mar 23) to 0.95, marking a decrease of 1.01.
For Current Ratio (X), as of Mar 24, the value is 9.75. This value exceeds the healthy maximum of 3. It has increased from 4.17 (Mar 23) to 9.75, marking an increase of 5.58.
For Quick Ratio (X), as of Mar 24, the value is 9.17. This value exceeds the healthy maximum of 2. It has increased from 3.22 (Mar 23) to 9.17, marking an increase of 5.95.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 5.03. This value is within the healthy range. It has increased from 4.24 (Mar 23) to 5.03, marking an increase of 0.79.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 8.69. This value is below the healthy minimum of 20. It has increased from 3.89 (Mar 23) to 8.69, marking an increase of 4.80.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 7.66. This value is below the healthy minimum of 20. It has increased from 3.46 (Mar 23) to 7.66, marking an increase of 4.20.
For Earning Retention Ratio (%), as of Mar 24, the value is 91.31. This value exceeds the healthy maximum of 70. It has decreased from 96.11 (Mar 23) to 91.31, marking a decrease of 4.80.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 92.34. This value exceeds the healthy maximum of 70. It has decreased from 96.54 (Mar 23) to 92.34, marking a decrease of 4.20.
For Interest Coverage Ratio (X), as of Mar 24, the value is 33.31. This value is within the healthy range. It has decreased from 45.16 (Mar 23) to 33.31, marking a decrease of 11.85.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 23.54. This value is within the healthy range. It has decreased from 33.48 (Mar 23) to 23.54, marking a decrease of 9.94.
For Enterprise Value (Cr.), as of Mar 24, the value is 518.25. It has increased from 489.04 (Mar 23) to 518.25, marking an increase of 29.21.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.59, marking an increase of 0.30.
For EV / EBITDA (X), as of Mar 24, the value is 3.90. This value is below the healthy minimum of 5. It has increased from 2.28 (Mar 23) to 3.90, marking an increase of 1.62.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.42 (Mar 23) to 0.97, marking an increase of 0.55.
For Retention Ratios (%), as of Mar 24, the value is 91.30. This value exceeds the healthy maximum of 70. It has decreased from 96.10 (Mar 23) to 91.30, marking a decrease of 4.80.
For Price / BV (X), as of Mar 24, the value is 1.05. This value is within the healthy range. It has increased from 0.94 (Mar 23) to 1.05, marking an increase of 0.11.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.42 (Mar 23) to 0.97, marking an increase of 0.55.
For EarningsYield, as of Mar 24, the value is 0.09. This value is below the healthy minimum of 5. It has decreased from 0.21 (Mar 23) to 0.09, marking a decrease of 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Sree Rayalaseema Hi-Strength Hypo Ltd as of March 17, 2025 is: ₹417.89

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 17, 2025, Sree Rayalaseema Hi-Strength Hypo Ltd is Overvalued by 15.24% compared to the current share price 493.00

Intrinsic Value of Sree Rayalaseema Hi-Strength Hypo Ltd as of March 17, 2025 is: 453.26

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 17, 2025, Sree Rayalaseema Hi-Strength Hypo Ltd is Overvalued by 8.06% compared to the current share price 493.00

Last 5 Year EPS CAGR: 8.46%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 15.58%, which is a positive sign. The company has higher reserves (386.08 cr) compared to borrowings (58.00 cr), indicating strong financial stability. The company has shown consistent growth in sales (467.15 cr) and profit (65.92 cr) over the years.	The stock has a high average Working Capital Days of 41.75, which may not be favorable. The stock has a high average Cash Conversion Cycle of 37.42, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sree Rayalaseema Hi-Strength Hypo Ltd:
1. Net Profit Margin: 9.11%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 14.2% (Industry Average ROCE: 15.23%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 9.86% (Industry Average ROE: 10.7%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 23.54
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 9.17
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 8.93 (Industry average Stock P/E: 218.12)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.01
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Sree Rayalaseema Hi-Strength Hypo Ltd. is a Public Limited Listed company incorporated on 28/03/2005 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L24110AP2005PLC045726 and registration number is 045726. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 866.01 Cr. and Equity Capital is Rs. 17.16 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Inorganic - Others	Gondiparla, Kurnool Andhra Pradesh 518004	srhypo@tgvmail.net http://www.tgvgroup.com

Management
Name	Position Held
Mr. T G Shilpa Bharath	Chairperson & Managing Director
Mr. H Gurunath Reddy	Non Executive Director
Mr. Satyam Gadwal	Non Executive Director
Mr. A Kailashnath	Independent Director
Mr. P Ramachandra Gowd	Independent Director
Mrs. R Triveni	Independent Woman Director

FAQ

What is the latest intrinsic value of Sree Rayalaseema Hi-Strength Hypo Ltd?

The latest intrinsic value of Sree Rayalaseema Hi-Strength Hypo Ltd as on 17 March 2025 is 417.89, which is 15.24% lower than the current market price of ₹493.00, indicating the stock is overvalued by 15.24%. The intrinsic value of Sree Rayalaseema Hi-Strength Hypo Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹846 Cr. and recorded a high/low of ₹944/439 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹859 Cr and total liabilities of ₹1,008 Cr.

What is the Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd?

The Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd is 846 Cr..

What is the current Stock Price of Sree Rayalaseema Hi-Strength Hypo Ltd as on 17 March 2025?

The current stock price of Sree Rayalaseema Hi-Strength Hypo Ltd as on 17 March 2025 is ₹493.

What is the High / Low of Sree Rayalaseema Hi-Strength Hypo Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Sree Rayalaseema Hi-Strength Hypo Ltd stocks is ₹944/439.

What is the Stock P/E of Sree Rayalaseema Hi-Strength Hypo Ltd?

The Stock P/E of Sree Rayalaseema Hi-Strength Hypo Ltd is 8.93.

What is the Book Value of Sree Rayalaseema Hi-Strength Hypo Ltd?

The Book Value of Sree Rayalaseema Hi-Strength Hypo Ltd is 510.

What is the Dividend Yield of Sree Rayalaseema Hi-Strength Hypo Ltd?

The Dividend Yield of Sree Rayalaseema Hi-Strength Hypo Ltd is 0.61 %.

What is the ROCE of Sree Rayalaseema Hi-Strength Hypo Ltd?

The ROCE of Sree Rayalaseema Hi-Strength Hypo Ltd is 15.7 %.

What is the ROE of Sree Rayalaseema Hi-Strength Hypo Ltd?

The ROE of Sree Rayalaseema Hi-Strength Hypo Ltd is 11.4 %.

What is the Face Value of Sree Rayalaseema Hi-Strength Hypo Ltd?

The Face Value of Sree Rayalaseema Hi-Strength Hypo Ltd is 10.0.